Moffitt Study Finds Neoadjuvant Chemotherapy Significantly Improves Outcomes for Penile Squamous Cell Carcinoma Patients

In a new article published in the Journal of the National Cancer Institute, Moffitt Cancer Center researchers share data on the efficacy and safety of neoadjuvant chemotherapy for locally advanced penile squamous cell carcinoma, addressing a critical gap in evidence regarding treatment options for this rare and aggressive cancer.